Professional Advisory Board

Our Professional Advisory Board provides ADHD Europe with its depth of scientific knowledge, giving advice based on their wide ranging experience in ADHD and comorbid conditions. To find out more about one of its members, please click on their name.

Dr Sandra Kooij

  • PsyQ, psycho-medical programs, Program and Expertise Center Adult ADHD, The Hague, The Netherlands
  • VUMc Amsterdam, dept. of psychiatry

Sandra Kooij started as a psychiatrist in 1995 with the development of diagnostic assessment, treatment and research in the field of adult ADHD in the Netherlands. In 2006 she received her PhD on a thesis entitled ‘ADHD in adults. Clinical studies on Assessment and Treatment’ at Radboud University Nijmegen (promotor prof. dr. J.K. Buitelaar). Since then, she has been involved for more than 20 years in ADHD research, patientcare, development of new trainings for professionals, informing the public, coordinating (inter)national networks on ADHD, publishing books, articles, and websites.

Main research interests: ADHD and sleep, disturbances of the circadian rhythm, mood, weight and health, and the relationship with hormonal changes in women. ADHD in older people is another interest.

(Inter)national tasks and positions

  • 2016 – current   Associate Professor of Psychiatry at VU University Medical Center, Amsterdam
  • 2002 – current Initiator and Head of Program and Expertise Center    Adult ADHD at PsyQ. Program Adult ADHD in the Hague treats annually around 1250 adult ADHD patients with

comorbidity, by a specialised multidisciplinary team. The expertise center is an (inter)national research and education institute that develops, distributes and implements new knowledge about ADHD in adults in mental health care in the Netherlands and abroad. The knowledge is distributed by scientific and popular publications, education programs, websites and films (

In 2008 and in 2013, Program and Expertise Center Adult ADHD received the TOP Mental Health (TOPGGz) acknowledgement, for excellent patientcare, education and research (

  • 2010 – current   Specialist-leader Adult ADHD at PsyQ in the Netherlands, responsible for the training and support of the 34 locations of PsyQ in the Netherlands. Each location has a specialised Adult ADHD Program (
  • 2015 – current Specialist-leader Neurobiological Developmental Disorders at Parnassia Group in the Netherlands
  • 2010 – 2015 Chair of the Guideline committee on Adult ADHD of the Dutch organisation of Psychiatry. The guideline was published sept 2015.
  • 2011 – current Initiator of the Lifespan ADHD Clinic at PsyQ in cooperation with child psychiatry, Lucertis & the Jutters, the Hague. In 2016 extended with ADHD in old age.
  • 2003 – current      Initiator and chair of the ‘European Network Adult ADHD’, in which now adult ADHD specialists from 27 countries take part
  • 2009 – current Initiator and chair of the international DIVA Foundation that distributes free of charge, online translations of the Dutch Diagnostic Interview for ADHD in adults (DIVA 2.0) that has been translated in 20 languages ( In 2012, the DIVA 2.0 App was launched via the App and Google Play store.
  • 2014 – current Initiator of ADHDFund, an international online crowdfund for patient driven research on ADHD (
  • 2008 – current Board member of APSARD, the American Psychiatric Society on ADHD and Related Disorders
  • 2010 – current Member of the Scientific Program committee of the World ADHD Congress
  • 2017 Advisory Board of ADHD Europe
  • 2017 Member of Eunethydis, European research network on ADHD

Professor Philip Asherson

Information to follow…

Dr Anthony Ramos

  • Doctor of Psychiatry and Clinical Psychology
  • University of Barcelona (UAB), Master in Systemic Family Therapy from the UAB.
  • Specialist in Psychiatry, Associate Professor of the Faculty of Medicine of the UAB, holder accredited by the National Agency for Evaluation and Prospective (ANECA) and the Agència per a Qualitat del Sistema Universitari de Catalunya (AQU).
  • Responsible for the research line of Attention Deficit Hyperactivity Disorder in the Adult (ADHD) of the group of psychiatry and mental health of the Vall d’Hebron Institut de Recerca (VHIR) of Barcelona

Dr Barbara Franke

Barbara Franke is a Professor of Molecular Psychiatry at the Radboud University Medical Center and a Principal Investigator at the Donders Institute for Brain, Cognition and Behaviour in Nijmegen, The Netherlands.

After finishing her studies in Biology in Giessen (Germany) and Utrecht (The Netherlands), she obtained her PhD in molecular signal transduction from Utrecht University in 1999. For postdoctoral studies, she subsequently moved to Nijmegen, where she was appointed at the departments of Human Genetics and Psychiatry.

In 2012, she became a full professor. As a molecular biologist and geneticist, her research is focused on understanding the genetic contribution to (neurodevelopmental) psychiatric disorders. In addition to gene-identification approaches involving common and rare genetic variation, she uses bioinformatics, neuroimaging genetics, and fruit fly models to map the biological pathways leading from gene to disease.

It is her goal to make genetic information useful for improving the diagnosis and treatment of psychiatric disorders. Barbara Franke leads and has lead several EU-funded consortium projects investigating the etiology of ADHD and related psychiatric disorders, including the EU FP7-funded Aggressotype project. the EU Horizon 2020 Marie Sklodowska-Curie Innovative Training Network MiND, and the Horizon 2020 PRIME project. In addition, she leads/has lead work packages in several additional EU-funded projects, the TACTICS, IMAGEMEND, CoCA, and Eat2beNICE projects.

Prof. Franke is a member of Academia Europaea, the Royal Netherlands Academy of Arts and Sciences, and the Royal Holland Society of Sciences and Humanities. She holds an honorary Adjunct Professorship at Goethe University in Frankfurt am Main, Germany, and an honorary Skou Professorship at Aarhus University in Aarhus, Denmark.

Tobias Banaschewski, MD, PhD

Tobias Banaschewski, MD, PhD, is Professor of Child and Adolescent Psychiatry at the Medical Faculty Mannheim of the University of Heidelberg, Medical Director of the Department of Child and Adolescent Psychiatry of the Central Institute of Mental Health (CIMH), as well as and Deputy Director of the CIMH in Mannheim, Germany. Dr. Banaschewski studied psychology and medicine at the University of Marburg in Germany. He worked as Clinical Assistant in Adult Psychiatry in Marburg and as Clinical and Research Assistant in Child & Adolescent Psychiatry at the University of Göttingen.

Memberships (selection):

  • President of the German Society of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (DGKJP) until 12/2017
  • Chair of the European Network for Hyperkinetic Disorders (EUNETHYDIS)
  • Board member of the German ADHD network
  • European College of Neuropsychopharmacology
  • Advisory Board of ADHD Europe

Research areas:

  • Psychopathology, neuropsychology, neurophysiology, and psychopharmacology of ADHD and comorbid disorders (autism, conduct disorder, dyslexia; tic disorder)


  • > 380 original papers & review articles, 3 books, 2 edited books, 32 book chapters; h-factor (Web of science): 56


  • Kramer-Pollnow Award 2003 (German Research Award for Biological Child and Adolescent Psychiatry)
  • August-Homburger Award 2014

Ongoing Research Support:

  • EU FP7: Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) (2010-2015)
  • EU FP7: Translational approaches to compulsivity disorders (TACTICS) (2012-2017)
  • EU FP7: Aggression subtyping for improved insight and treatment innovation in paediatric psychiatric disorders (AGGRESSOTYPE) (2013-2018)
  • EU FP7: High callous-unemotional traits and aggression (MATRICS) (2013-2018)
  • EU FP7: Pediatric European Risperidone Studies (PERS) (2010-2015)
  • EU FP7: Suicidality: Treatment Occurring in Pediatric (STOP) (2010-2015)
  • EU-AIMS, Innovative Medicines Initiative EU grant (2012-2018)
  • Kings-College, London: IMAGEN project follow-up (2007-2020)
  • German FMER: Research Network ESCALIFE (2015-2020)

Susan J. Young, BSc (Hons), DClinPsy, PhD, CSi, AFBPS

Professor Susan Young ( is a clinical and forensic psychologist, and a practitioner neuropsychologist with over 20 years working in clinical academia, including prestigious employment at Imperial College London.

She participated in the National Institute for Health and Clinical Excellence (NICE) ADHD Clinical Guideline Development Group (2008;2013) and the British Association of Psychopharmacology ADHD Consensus Meetings (2007;2013).

She is President of the UK ADHD Partnership, Trustee of The ADHD Foundation and is on the Professional Advisory Board of ADHD Europe.

Professor Young has published over 150 articles in scientific journals. She has published as first or sole author five psychological intervention programmes, four books, the ADHD Child Evaluation [ACE] and ACE+ for assessment of adults with ADHD, and the Diagnostic Autism Spectrum Interview [DASI]

Her work has been translated into Afrikaans, Spanish, Catalan, Icelandic, Hebrew, Japanese, Danish, Swedish, Norwegian, Polish, Chinese, French, Turkish, Dutch, Polish, Italian, Russian, Hungarian, Macedonian, Tamil, Arabic, Greek, Brazilian Portuguese, Persian and Sinhalese.

Dr Kate Carr Fanning

Kate is a Lecturer and the Course Director for Childhood and Youth Studies in the School of Psychological, Social, and Behavioural Sciences in Coventry University.

Kate is a psychologist who specialises in special educational needs and inclusive education, especially for students with ADHD. She completed her PhD in Trinity College Dublin focusing on the inclusion of students with ADHD in mainstream schools in Ireland.

Kate’s research interests are education for students with ADHD, psychosocial interventions for ADHD, psychoeducation, mental health promotion, and participatory research and practice (especially children voice / student voice / patient voice).

Kate has over ten years experience working with charities and schools across Europe and in the USA working with children, parents, and professionals supporting the needs of children and adults with ADHD.

Kate sits on the Board of HADD / ADHD Ireland and is on the Professional Advisory Board of ADHD Europe. At present, Kate is working with the Health Service Executive (HSE) in Ireland to develop clinical guidelines for the diagnosis and treatment of adult ADHD.